Clinical Trials
71 trialsAdding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC
Jiangxi Provincial Cancer Hospital
A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
RenJi Hospital
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Shantou University Medical College
MITO-8
National Cancer Institute, Naples
CONTINUUM
Sun Yat-sen University
MILES-3
National Cancer Institute, Naples
MILES-4
National Cancer Institute, Naples
MITO16MANGO2b
National Cancer Institute, Naples
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
Kuwait Cancer Control Center
ChiCGB vs BEAM in High-risk or R/R Lymphomas
Sichuan University
Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd.
Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer
Samsung Medical Center
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Fudan University
AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer
Fudan University
NItCHE-MITO33
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC
Sun Yat-sen University
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.
Fudan University
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
Sun Yat-sen University
EPIC
University of Turin, Italy
A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
GEMFOX
Assistance Publique - Hôpitaux de Paris
Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
West China Hospital
POUT
Institute of Cancer Research, United Kingdom
HAIC Versus Systemic Chemotherapy for Unresectable ICC
Sun Yat-sen University
Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage
Fudan University
Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
AdBTC-1
Tianjin Medical University Cancer Institute and Hospital
SIMPLE Chemotherapy for NK Lymphoma/Leukaemia
The University of Hong Kong
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
HEAT
Klinikum der Universitaet Muenchen, Grosshadern
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
NSABP Foundation Inc
PERS
Sun Yat-sen University
A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
Samsung Pharmaceutical Co., Ltd.
CERVIPIB
The National Center of Oncology, Azerbaijan
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Xinqiao Hospital of Chongqing
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Fudan University
EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
Shanghai Pulmonary Hospital, Shanghai, China
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma
Fudan University
Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
GIP-2
Azienda Ospedaliero, Universitaria Pisana
Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Panc001
AHS Cancer Control Alberta
Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer
Southwest Hospital, China
Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)